---
title: "Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration"
description: "Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)"
url: "https://www.clareohealth.com/clinical-trials/NCT02339987"
---

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

## Key Facts

**ID:** NCT02339987
**Status:** TERMINATED
**Type:** OBSERVATIONAL
**Enrollment:** 27
**Sponsor:** Saint John's Cancer Institute

## Detailed Description

The purpose of this study is to allow the collection of tissue from subjects to be used in future research studies by scientists and to isolate tumor fighting cells for the future treatment of Melanoma.

## Conditions

- Melanoma

## Eligibility

Inclusion Criteria: 1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing resection for palliation, therapeutic or curative purpose. 2.

## Who Can Participate

**Minimum age:** 15

**Sex:** ALL

**Accepts healthy volunteers:** No

## Study Locations

- John Wayne Cancer Institute, Santa Monica, California, United States

## Contact Information

## Important Dates

**Study start:** November 1, 2014

**Completion date:** June 4, 2018

**Last updated:** February 21, 2019

[View on ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT02339987)
